Insider · CIK 0001973705
Anne Lesage
Files at PHVS (Pharvaris N.V.). First filing Apr 24, 2026, latest Sep 21, 2026.
Anne Lesage files SEC Form 4 as officer at PHVS (Pharvaris N.V.). Since Apr 24, 2026, Anne Lesage has reported 0 open-market buys worth $0 and 5 open-market sells worth $4.0M, the latest filed on Sep 21, 2026.
A track record needs three past buys with six months of prices behind them; Anne Lesage has 0, so none is measured yet.
The newest scored trade: sold $765k of PHVS on Sep 17, 2026, filed Sep 21, 2026, scored 57 (moderate). In the last 12 months: 0 buys worth $0 and 5 sells worth $4.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHVS: Pharvaris N.V.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Pharvaris N.V. | $765k 20,000 shares | -21% | - | |
| 30Weak | Pharvaris N.V. | $1.1M 30,000 shares | -35% | - | |
| 6Weak | Pharvaris N.V. | $162k 4,600 shares | -8% | +96% from low-0% from high | |
| 40Moderate | Pharvaris N.V. | $1.5M 48,300 shares | -80% | +93% from low-1% from high | |
| 22Weak | Pharvaris N.V. | $442k 14,700 shares | -26% | +103% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 30, 2026 | PHVS Pharvaris N.V. | 27,872 0.04% of outstanding | $967k | Jun 30, 2026 | $2.6M |
| Jun 30, 2026 | PHVS Pharvaris N.V. | 30,703 0.05% of outstanding | $1.1M | Jun 30, 2026 | $2.6M |
| Jun 29, 2026 | PHVS Pharvaris N.V. | 8,300 0.01% of outstanding | $282k | Jun 29, 2026 | $2.1M |
| Jun 29, 2026 | PHVS Pharvaris N.V. | 6,997 0.01% of outstanding | $238k | Jun 29, 2026 | $2.1M |
| Jun 25, 2026 | PHVS Pharvaris N.V. | 2,300 0.00% of outstanding | $77k | Jun 25, 2026 | $1.9M |
| Jun 25, 2026 | PHVS Pharvaris N.V. | 2,300 0.00% of outstanding | $77k | Jun 25, 2026 | $1.9M |
| Apr 22, 2026 | PHVS Pharvaris N.V. | 33,000 0.05% of outstanding | $962k | Apr 22, 2026 | none |
| Apr 22, 2026 | PHVS Pharvaris N.V. | 30,000 0.05% of outstanding | $875k | Apr 22, 2026 | none |
Transactions
Every row this insider has filed, 32 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: By GrayMatters Consulting BVBA | -20,000 | $38.27 | $765k | 73,969 | 22 d ago |
| Sep 10, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +30,000 | $8.05 | $242k | 86,450 | 29 d ago |
| Sep 10, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -30,000 | $38.30 | $1.1M | 56,450 | 29 d ago |
| Sep 10, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 15,000 | 29 d ago |
| Jun 25, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +1,400 | $2.59 | $3,626 | 57,850 | Jun 29, 2026 |
| Jun 25, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +900 | $8.05 | $7,245 | 58,750 | Jun 29, 2026 |
| Jun 25, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -2,300 | $35.12 | $81k | 56,450 | Jun 29, 2026 |
| Jun 25, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: By GrayMatters Consulting BVBA10b5-1 | -2,300 | $35.12 | $81k | 131,669 | Jun 29, 2026 |
| Jun 25, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -900 | $0.00 | $0 | 74,100 | Jun 29, 2026 |
| Jun 25, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,400 | $0.00 | $0 | 7,072 | Jun 29, 2026 |
| Apr 29, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +3,700 | $2.59 | $9,583 | 60,150 | May 1, 2026 |
| Apr 29, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -3,700 | $30.08 | $111k | 56,450 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +3,700 | $2.59 | $9,583 | 60,150 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -3,700 | $30.26 | $112k | 56,450 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +18,000 | $8.05 | $145k | 74,450 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -18,000 | $30.26 | $545k | 56,450 | May 1, 2026 |
| Apr 29, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: By GrayMatters Consulting BV10b5-1 | -3,700 | $30.06 | $111k | 153,169 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: By GrayMatters Consulting BV10b5-1 | -19,200 | $30.26 | $581k | 133,969 | May 1, 2026 |
| Apr 29, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,700 | $0.00 | $0 | 12,772 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,700 | $0.00 | $0 | 9,072 | May 1, 2026 |
| Apr 30, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,000 | $0.00 | $0 | 82,000 | May 1, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +500 | $2.59 | $1,295 | 56,950 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -500 | $30.00 | $15k | 56,450 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +7,000 | $8.05 | $56k | 63,450 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -7,000 | $30.05 | $210k | 56,450 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: GrayMatters Consulting B.V.10b5-1 | -7,000 | $30.05 | $210k | 156,969 | Apr 24, 2026 |
| Apr 23, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stockindirect: GrayMatters Consulting B.V.10b5-1 | -100 | $30.03 | $3,003 | 156,869 | Apr 24, 2026 |
| Apr 23, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock10b5-1 | +100 | $2.59 | $259 | 56,550 | Apr 24, 2026 |
| Apr 23, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock10b5-1 | -100 | $30.03 | $3,003 | 56,450 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -500 | $0.00 | $0 | 15,972 | Apr 24, 2026 |
| Apr 22, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,000 | $0.00 | $0 | 113,000 | Apr 24, 2026 |
| Apr 23, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -100 | $0.00 | $0 | 15,872 | Apr 24, 2026 |
Questions about Anne Lesage
Answered from the filings on this page, as of the latest one.
Is Anne Lesage buying or selling?
In the last 12 months Anne Lesage reported 0 open-market buys worth $0 and 5 open-market sells worth $4.0M on SEC Form 4; the latest was sold $765k of PHVS on Sep 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Anne Lesage's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anne Lesage has 0.
Where does Anne Lesage file Form 4?
Anne Lesage has filed Form 4 at PHVS (Pharvaris N.V.) as Chief Early Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.